(Q37467237)

English

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer

scientific article published on January 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Mark D Pegram

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Virginia F Borges

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Nuhad Ibrahim

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jyotsna Fuloria

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Charles Shapiro

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Susan Perez

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Karen Wang

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Franziska Schaedli Stark

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Nigel Courtenay Luck

9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Breast Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

R73

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Aromatase inhibitors for breast cancer: proven efficacy across the spectrum of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

23 August 2017

Trastuzumab : in HER2 and hormone receptor co-positive metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

23 August 2017

Trastuzumab for early breast cancer: current status and future directions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

23 August 2017

MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

23 August 2017

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

23 August 2017

MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

23 August 2017

MUC1 in carcinoma-host interactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

23 August 2017

Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

23 August 2017

Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

6 September 2017

MUC1 oncoprotein stabilizes and activates estrogen receptor alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

14 September 2017

MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

14 September 2017

Aromatase inhibitors increase the sensitivity of human tumor cells to monocyte-mediated, antibody-dependent cellular cytotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

14 September 2017

The MUC1 SEA module is a self-cleaving domain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

14 September 2017

Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

28 September 2017

Development of monoclonal antibodies for the treatment of colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

2 September 2018

Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790853

2 September 2018

Construction of a reshaped HMFG1 antibody and comparison of its fine specificity with that of the parent mouse antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/19811637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of MUC1 epithelial mucin expression in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19811637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/BCR2409

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37467237&oldid=2200408014"